The Latest Breaking News from PFE

Despite lingering macro disruptions, Street analysts expect pharma stock Pfizer (PFE) to gain double digits in the near term. Moreover, it pays a reliable dividend. Given its robust fundamentals, I think PFE might be an ideal buy for the long haul. Keep reading.

Pfizer (PFE) played a pivotal role in developing vaccines and pills that helped the world return to normal from the COVID-19 pandemic. The company reported record revenue and earnings in fiscal 2022. Given the company’s solid growth prospects, it could be wise to invest in the stock right now. Keep…

With Russia’s plans to cut crude oil production threatening to tip an interest-rate-paranoid market into a fresh bout of volatility and sell-off, shares of fundamentally strong and profitable businesses, such as Taiwan Semiconductor Manufacturing Company (TSM), Walmart (WMT), and Pfizer (PFE), seem to be good investments now. Continue reading….

Although the Fed is expected to go slow with rate hikes, they are not expected to end anytime soon. Moreover, the possibility of a recession cannot be ruled out yet. Given the uncertainties, fundamentally sound dividend stocks Pfizer (PFE) and Sisecam (SIRE) could be a solid addition to your portfolio…

Amid concerns that an estimate-beating labor market tightness may embolden the Fed to keep pushing interest rates upward, fundamentally strong stocks Pfizer (PFE), Verizon (VZ), and AT&T (T) have deservedly found takers on Wall Street. Read on….

With the recent market rally hinged on hopes of an end to the Fed’s hawkishness in the foreseeable future, strong fundamentals of Pfizer (PFE) for excellent value could help investors secure decent risk-adjusted returns on their investments. Read on….

Shares of Pfizer (PFE), Centene (CNC), and Kellogg (K) could provide a solid foundation to new portfolios for sustained wealth creation, given the fundamental strength, consistent profitability, and resilient demand of these companies. Continue reading….

Looming recession fears, the Federal Reserve’s persistent monetary tightening plans, and stubbornly high inflation continue to impact investor sentiment. Hence, it could be wise to add fundamentally sound stocks Pfizer (PFE), Rio Tinto (RIO), and Lockheed Martin (LMT) to beat the market fluctuations this year. Continue reading….

Pfizer (PFE) topped Wall Street’s EPS and revenue estimates in the third quarter. Moreover, the company updated its guidance for fiscal 2022. Analysts expect the stock to rise more than 16% in the near term. Therefore, it could be wise to buy the stock now. Keep reading….

Rising chronic diseases, an aging population, and surging healthcare spending should boost the pharmaceutical industry’s growth prospects. Moreover, the pharmaceutical industry usually holds up well during market downturns due to relatively inelastic demand for their products and services. Therefore, fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

Places for Everyone - the conurbation’s controversial long-term strategy for jobs and homes - is currently undergoing a public examination as part of the process towards it being signed off by the government.